Current Projects

Analysis and Publications (A&P)

Principal Investigator	Proposal Title
Gaurav Gulati, Tufts Medical Center	Kidney Disease, Right Ventricle Dysfunction and Outcomes in Older LVAD Recipients
Michael Kiernan, Tufts Medical Center	Partial Myocardial Recovery And Long-Term Post LVAD Outcomes
Jeff Teuteberg/Sung-Min Cho, Stanford University/Johns Hopkins University	Epidemiology and Outcomes of Patients Bridged to Heart Transplant with Durable LVAD Support
Indranee Rajapreyar, Tufts Medical Center	Late Right Heart Failure after Left Ventricular Assist Device Implantation: Impact on Outcomes and Association with Adverse Events Beyond One Year
Todd Dardas, University of Washington	Modeling days alive and out of hospital for durable left ventricular assist device support
Daniel Goldstein, Montefiore Medical Center	Examining the Adverse Events Profile of BTT/BTC Patients after the UNOS Allocation Changes
James Mehaffey, West Virginia University	Mortality risk prediction for patients who receive a HeartMate3 left ventricular assistance device
Humera Ahmed, Children’s Hospital of Philadelphia	Explainable Machine Learning To Assess The Risk For Right Heart Failure During Pediatric Left Ventricular Assist Device Placement
Waldemar Carlo, University of Alabama at Birmingham	Comparison of Outcomes Between Heartmate 3 and Cardiac Transplantation in Adolescents with Dilated Cardiomyopathy
Joseph Rossano, Children’s Hospital of Philadelphia	Long Term Ventricular Assist Devices in Children

Participant User File (PUF)

Principal Investigator	Proposal Title
Erin Schumer	Outcomes of Patients with Left Ventricular Assist Device Based on Distance From Implant Center
Harikesh Subramanian	Effects Of Social Determinants Of Health (Sdoh) On Complications After VAD Implantation: Exploration Of The ZIP Code And Outcomes
Omar Saeed, Montefiore Medical Center, Albert Einstein	Neurologic Dysfunction in Patients with Contemporary Magnetically Levitated Left Ventricular Assist Devices
Paul Tang, Mayo Clinic	Preoperative Passive Cardiac Index Determines Left Ventricular Assist Device Outcomes
Lauren Cooper, Northwell Health	Guideline Directed Medical Therapy (GDMT) for Heart Failure in Patients with Durable Left Ventricular Assist Devices (LVAD)
Donna Mancini, Icahn School of Medicine at Mount Sinai	Advanced Chronic Kidney Disease and Ventricular Assist Device Outcomes: An Analysis of the STS INTERMACS Database
Vinod Thourani, Piedmont Healthcare	Characterization of the natural history of aortic regurgitation in LVAD patients: an INTERMACS analysis
Leora Balsam, UMass Chan Medical School	INTERMACS Registry Trends and Outcomes after Heartmate 3 Left Ventricular Assist Device Implantation: The Impact of Surgical Approach
Keith Aaronson, University of Michigan	A novel model to predict Gastrointestinal bleeding after a Heartmate 3 LVAD implantation
Eric Adler, University of California-San Diego	Machine learning for prognostication in advanced heart failure
Jerry Estep, Cleveland Clinic	Predictors of hospital readmission burden and survival analysis in patients with contemporary continuous flow left ventricular assist device (CF-LVAD)
Lucian Lozonschi  Medical University of South Carolina	Ventricular arrhythmia post cf-left ventricular assist device placement – Trends within the STS Intermacs in the contemporary era
Duc Thinh Pham, Northwestern University	Risk assessment model for wait list mortality in left ventricular assist device patients
Edward Grandin, Beth Israel Deaconess Medical Center	Assessing the impact of beta-blockers on late right heart failure and survival after left ventricular assist device implantation